1. van den Borst B, Gosker HR, Zeegers MP, Schols AM. Pulmonary function in diabetes: a metaanalysis. Chest. 2010;138(2):393-406.
2. Lecube A, Sampol G, Muñoz X, Hernández C, Mesa J, Simó R. Type 2 diabetes impairs pulmonary function in morbidly obese women: a case–control study. Diabetologia. 2010;53(6):1210-6.
3. Vanidassane I, Malik R, Jain N. Study of pulmonary function tests in Type 2 Diabetes Mellitus and their correlation with glycemic control and systemic inflammation. Advances in respiratory medicine. 2018;86(4):172-8.
4. Pramodh V, Akhila N. Pulmonary Function Tests in Type 2 Diabetes. IOSR Journal of Dental and Medical Sciences. 2015;14:44-7.
5. Benfield T, Jensen J, Nordestgaard B. Influence of diabetes and hyperglycaemia on infectious disease hospitalisation and outcome. Diabetologia. 2007;50(3):549-54.
6. Dennis RJ, Maldonado D, Rojas MX, Aschner P, Rondón M, Charry L, et al. Inadequate glucose control in type 2 diabetes is associated with impaired lung function and systemic inflammation: a cross-sectional study. BMC Pulmonary medicine. 2010;10(1):38.
7. Kishore U, Greenhough TJ, Waters P, Shrive AK, Ghai R, Kamran MF, et al. Surfactant proteins SP-A and SP-D: structure, function and receptors. Molecular immunology. 2006;43(9):1293-315.
8. Wright JR. Immunoregulatory functions of surfactant proteins. Nature reviews Immunology. 2005;5(1):58-68.
9. López-Cano C, Lecube A, García-Ramírez M, Muñoz X, Sánchez E, Seminario A, et al. Serum surfactant protein D as a biomarker for measuring lung involvement in obese patients with type 2 diabetes. The Journal of Clinical Endocrinology & Metabolism. 2017;102(11):4109-16.
10. Ju C-R, Liu W, Chen R-C. Serum surfactant protein D: biomarker of chronic obstructive pulmonary disease. Disease markers. 2012;32(5):281-7.
11. Rajagopalan S, Brook RD. Air pollution and type 2 diabetes: mechanistic insights. Diabetes. 2012;61(12):3037-45.
12. Shore SA. Obesity and asthma: possible mechanisms. The Journal of allergy and clinical immunology. 2008;121(5):1087-93; quiz 94-5.
13. Sorensen G, Hjelmborg JvB, Leth‐Larsen R, Schmidt V, Fenger M, Poulain F, et al. Surfactant protein D of the innate immune defence is inversely associated with human obesity and SP‐D deficiency infers increased body weight in mice. Scandinavian journal of immunology. 2006;64(6):633-8.
14. Pueyo N, Ortega FJ, Mercader JM, Moreno-Navarrete JM, Sabater M, Bonàs S, et al. Common genetic variants of surfactant protein-D (SP-D) are associated with type 2 diabetes. PLoS One. 2013;8(4):e60468.
15. Fernández-Real JM, Valdés S, Manco M, Chico B, Botas P, Campo A, et al. Surfactant protein d, a marker of lung innate immunity, is positively associated with insulin sensitivity. Diabetes care. 2010;33(4):847-53.
16. Oberley RE, Goss KL, Dahmoush L, Ault KA, Crouch EC, Snyder JM. A role for surfactant protein D in innate immunity of the human prostate. The Prostate. 2005;65(3):241-51.
17. Christensen A, Hoegh S, Lottenburger T, Holmskov U, Tornoe I, Hørslev-Petersen K, et al. Circadian rhythm and the influence of physical activity on circulating surfactant protein D in early and long-standing rheumatoid arthritis. Rheumatology international. 2011;31(12):1617-23.
18. Hip osteoarthritis can be treated with exercise. While no cure exists to date for this degenerative disease, exercise therapy can help alleviate symptoms and stave off surgery. Duke Med Health News. 2014;20(12):3.
19. Loimaala A, Groundstroem K, Rinne M, Nenonen A, Huhtala H, Parkkari J, et al. Effect of long-term endurance and strength training on metabolic control and arterial elasticity in patients with type 2 diabetes mellitus. The American journal of cardiology. 2009;103(7):972-7.
20. Trevino-Alanis M, Ventura-Juarez J, Hernandez-Pinero J, Nevarez-Garza A, Quintanar-Stephano A, Gonzalez-Pina A. Delayed lung maturation of foetus of diabetic mother rats develop with a diminish, but without changes in the proportion of type I and II pneumocytes, and decreased expression of protein D-associated surfactant factor. Anatomia, histologia, embryologia. 2009;38(3):169-76.
21. Punitha IS, Rajendran K, Shirwaikar A, Shirwaikar A. Alcoholic stem extract of Coscinium fenestratum regulates carbohydrate metabolism and improves antioxidant status in streptozotocin-nicotinamide induced diabetic rats. Evidence-based complementary and alternative medicine : eCAM. 2005;2(3):375-81.
22. Kim HJ, So B, Son JS, Song HS, Oh SL, Seong JK, et al. Resistance training inhibits the elevation of skeletal muscle derived-BDNF level concomitant with improvement of muscle strength in zucker diabetic rat. Journal of exercise nutrition & biochemistry. 2015;19(4):281-8.
23. Ghanayem NM, Elnour ESA, El Wahsh RA, El-Shazlya RM, Elenin MAA. Surfactant protein D in chronic obstructive pulmonary disease and type 2 diabetes mellitus. Menoufia Medical Journal. 2017;30(1):297.
24. Doyle IR, Jones ME, Barr HA, Orgeig S, Crockett AJ, McDonald CF, et al. Composition of human pulmonary surfactant varies with exercise and level of fitness. American journal of respiratory and critical care medicine. 1994;149(6):1619-27.
25. Doyle IR, Morton S, Crockett AJ, Barr HA, Davidson KG, Jones MJ, et al. Composition of alveolar surfactant changes with training in humans. Respirology. 2000;5(3):211-20.
26. Stidsen JV, Khorooshi R, Rahbek MK, Kirketerp-Møller KL, Hansen PB, Bie P, et al. Surfactant protein d deficiency in mice is associated with hyperphagia, altered fat deposition, insulin resistance, and increased basal endotoxemia. PloS one. 2012;7(4):e35066.
27. Ortega F, Pueyo N, Moreno-Navarrete J, Sabater M, Rodriguez-Hermosa J, Ricart W, et al. The lung innate immune gene surfactant protein-D is expressed in adipose tissue and linked to obesity status. International Journal of Obesity. 2013;37(12):1532.
28. Jawed S, Mannan N, Qureshi MA. Association of surfactant protein-d with obesity. Journal of Ayub Medical College Abbottabad. 2016;28(3):489-92.
29. Stidsen JV, Khorooshi R, Rahbek MK, Kirketerp-Moller KL, Hansen PB, Bie P, et al. Surfactant protein d deficiency in mice is associated with hyperphagia, altered fat deposition, insulin resistance, and increased basal endotoxemia. PloS one. 2012;7(4):e35066.
30. Hall KE, McDonald MW, Grisé KN, Campos OA, Noble EG, Melling CJ. The role of resistance and aerobic exercise training on insulin sensitivity measures in STZ-induced Type 1 diabetic rodents. Metabolism. 2013;62(10):1485-94.
31. Kido K, Ato S, Yokokawa T, Sato K, Fujita S. Resistance training recovers attenuated APPL1 expression and improves insulin-induced Akt signal activation in skeletal muscle of type 2 diabetic rats. American Journal of Physiology-Endocrinology and Metabolism. 2018;314(6):E564-E71.
32. Riehle C, Wende AR, Zhu Y, Oliveira KJ, Pereira RO, Jaishy BP, et al. Insulin receptor substrates are essential for the bioenergetic and hypertrophic response of the heart to exercise training. Molecular and cellular biology. 2014;34(18):3450-60.
33. Miranda TS, Heluy SL, Cruz DF, da Silva HDP, Feres M, Figueiredo LC, et al. The ratios of pro-inflammatory to anti-inflammatory cytokines in the serum of chronic periodontitis patients with and without type 2 diabetes and/or smoking habit. Clinical oral investigations. 2018:1-10.